NO20063327L - Bruseapparat av en basisk medisinsk substans - Google Patents

Bruseapparat av en basisk medisinsk substans

Info

Publication number
NO20063327L
NO20063327L NO20063327A NO20063327A NO20063327L NO 20063327 L NO20063327 L NO 20063327L NO 20063327 A NO20063327 A NO 20063327A NO 20063327 A NO20063327 A NO 20063327A NO 20063327 L NO20063327 L NO 20063327L
Authority
NO
Norway
Prior art keywords
medical substance
basic medical
shower apparatus
shower
composition
Prior art date
Application number
NO20063327A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Irene Loose
Ralf Buellesbach
Dieter Rehn
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20063327L publication Critical patent/NO20063327L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Foreliggende oppfinnelse angår et brusepreparat som irmeholder en brusemiddelbatch, minst en basis medisinsk substans og et eller flere eventueUe midler. Nevnte brusepreparat er kjermetegnet ved at alikalisering av urin, og således økt akkumulering av den basiske medisinske substansen, hindres. Også beskrevet er medikamenter som irmeholder nevnte brusepreparat, fremgangsmåte for fremstiUing derav og anvendelse derav.
NO20063327A 2003-12-19 2006-07-18 Bruseapparat av en basisk medisinsk substans NO20063327L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz
PCT/EP2004/013886 WO2005063199A1 (de) 2003-12-19 2004-12-07 Brausezubereitung einer basischen arzneilich wirksamen substanz

Publications (1)

Publication Number Publication Date
NO20063327L true NO20063327L (no) 2006-07-18

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063327A NO20063327L (no) 2003-12-19 2006-07-18 Bruseapparat av en basisk medisinsk substans

Country Status (16)

Country Link
EP (1) EP1696874A1 (no)
JP (1) JP2007515418A (no)
KR (1) KR20060109492A (no)
CN (1) CN1893920A (no)
AR (1) AR046955A1 (no)
AU (1) AU2004308590A1 (no)
BR (1) BRPI0417796A (no)
CA (1) CA2550342A1 (no)
DE (1) DE10359790A1 (no)
EC (1) ECSP066649A (no)
IL (1) IL176356A0 (no)
MA (1) MA28276A1 (no)
MX (1) MXPA06006658A (no)
NO (1) NO20063327L (no)
WO (1) WO2005063199A1 (no)
ZA (1) ZA200604946B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
JP5614557B2 (ja) * 2009-05-27 2014-10-29 ダサン メディケム カンパニー リミテッド 発泡層を含む多層錠剤
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN107951034B (zh) * 2017-12-01 2021-03-23 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
AU7407194A (en) * 1993-08-03 1995-02-28 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Also Published As

Publication number Publication date
AU2004308590A1 (en) 2005-07-14
BRPI0417796A (pt) 2007-03-20
CN1893920A (zh) 2007-01-10
AR046955A1 (es) 2006-01-04
WO2005063199A1 (de) 2005-07-14
MXPA06006658A (es) 2006-08-31
CA2550342A1 (en) 2005-07-14
EP1696874A1 (de) 2006-09-06
KR20060109492A (ko) 2006-10-20
JP2007515418A (ja) 2007-06-14
ZA200604946B (en) 2007-09-26
MA28276A1 (fr) 2006-11-01
ECSP066649A (es) 2006-10-25
IL176356A0 (en) 2006-10-05
DE10359790A1 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
NO20003514L (no) Hypolipidemiske benzothiazepin-forbindelser
NO20041041L (no) Fenetanolaminderivater for behandling av respiratoriske sykdommer
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
TNSN00065A1 (fr) Derives nouveaux de pyrimidine inhibiteurs de sorbitol- deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant.
MA26709A1 (fr) Compositions pharmaceutiques de celecoxib, leurs procedes de preparation et methodes de traitement les utilisant
NO20032734D0 (no) Nye 1,2-difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder nevnte forbindelser og anvendelse avdisse for behandling av sykdommer fra lipidstoffskiftet
NO20063327L (no) Bruseapparat av en basisk medisinsk substans
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
PT1200412E (pt) Agentes anti-proliferativos de imidazole
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
NO20064982L (no) 1,3,4-oksadiazol-2-oner som PPAR delta modulatorer og anvendelse derav
EE200300234A (et) Bifenüülkarboksamiidühendite kasutamine lipiiditaset alandavate toimeainetena, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
DE602004002394D1 (de) (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN
ATE334979T1 (de) Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
SE9804212D0 (sv) Compounds
ATE332894T1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
NO20055754L (no) Kolkisosidanaloger
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE399778T1 (de) Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon
TNSN99146A1 (fr) Derives de 1-heteroaryl-pyrrolidine, -piperidine et - homopiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DE60041137D1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application